Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 20-28, January 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conklin, J. W.
Right arrow Articles by Christenberry, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conklin, J. W.
Right arrow Articles by Christenberry, K. W.

Further Observations on Late Somatic Effects of Radiomimetic Chemicals and X-Rays in Mice1

J. W. Conklin, A. C. Upton and K. W. Christenberry

( Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee)

Young adult female RF mice were subjected to four successive midlethal doses of nitrogen mustard (HN2), triethylene melamine (TEM), 1,4-dimethanesulfonoxybutane (myleran), or whole-body x-rays. The agents were given at 14-day intervals, and the survivors were observed for effects on longevity and on the incidence of late occurring diseases. The percentages of mice dying within 30 days after treatment in the various groups were: TEM, 12.5%; HN2, 10%; myleran, 3%; x-rays, 1%; and control, 1%. The life-span of 30-day survivors was shortened in all treated groups, with mean survival times as follows: x-rays, 355 days; TEM, 427 days; HN2, 490 days; myleran, 511 days; and controls, 632 days. Although all the agents were highly oncogenic, the decrease in longevity was not attributable solely to neoplasia, but was correlated with premature mortality in various diseases associated with aging. Thymic lymphomas were induced by all agents, but myeloid leukemia only by x-rays. The incidence of ovariant tumors was increased by TEM, myleran, and x-rays. The incidence of pulmonary adenomas was increased by HN2 and TEM. All agents caused premature development of lens opacities, but only myleran and x-rays induced lens changes significantly more severe than those developing spontaneously in senile controls.

1 Research jointly sponsored by the National Cancer Institute, and the United States Atomic Energy Commission under contract with the Union Carbide Corporation.

Received 8/14/64.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.